Waltham, MA · Founded 2017 · Privately Held (backing)
Developer of a blood test technology designed to detect specific cancer subtypes and improve patient outcomes. Naveris is based in Waltham, MA and was founded in 2017. Its last known valuation is $81.5 million. It has raised $85.5 million across 3 recorded rounds; the latest was a $17.5 million early-stage round in Jun 2024.
Last price · $/share
—
Implied valuation
$81.5M
Total raised
$85.5M
Last round
Early Stage VC
Jun 2024
Cap table — not yet on record
Naveris's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Naveris with a free account
·Watch Naveris: the Monday email on marks, rounds and moves